Transcatheter edge-to-edge mitral valve repair using MitraClip successfully reduced mitral regurgitation and allowed weaning from vasopressors in two patients with refractory cardiogenic shock.
Case Report (n=2)
No
Does Transcatheter edge-to-edge mitral valve repair (TEER) using MitraClip improve outcomes in patients with cardiogenic shock secondary to acute ischemic mitral regurgitation?
TEER using MitraClip may be a viable rescue therapy for patients presenting with cardiogenic shock secondary to acute ischemic mitral regurgitation.
Cardiogenic shock (CS) in the setting of acute coronary syndrome carries detrimental consequences and high levels of mortality and morbidity if not managed promptly. Acute mitral regurgitation (MR) as a complication of the myocardial infarction might superimpose refractory CS that warrants mitral valve repair. There has been growing use of Transcatheter edge-to-edge mitral valve repair (TEER) as a therapy for CS secondary to acute MR. In this cohort, we describe two cases of CS secondary to acute ischemic MR managed with a Mitraclip.
Ahmed et al. (Sun,) conducted a case report in Cardiogenic shock secondary to acute ischemic mitral regurgitation (n=2). Transcatheter edge-to-edge mitral valve repair (TEER) using MitraClip was evaluated on Hemodynamic improvement and reduction in mitral regurgitation grade. Transcatheter edge-to-edge mitral valve repair using MitraClip successfully reduced mitral regurgitation and allowed weaning from vasopressors in two patients with refractory cardiogenic shock.